Cite
HARVARD Citation
Jagirdar, N. et al. (2015). Plerixafor in combination with granulocyte–colony‐stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial. Transfusion. 55 (10), pp. 2351-2357. [Online].